Profile
| Metric | Value |
|---|---|
| Full Name | Schrödinger, Inc. |
| Ticker | NASDAQ: SDGR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | schrodinger.com |
| Employees | 891 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $17.98 | |
| Price, 1D Change | +0.56% | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.37 | |
| Revenue | $208M | |
| Revenue, 1Y Change | -4.21% | |
| EPS | -$2.58 | |
| EPS, 1Y Change | -574.22% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$2.58 | |
| EPS Estimate | -$2.03 | |
| EPS Est. Change | +21.36% | |
| Revenue | $207.54M | |
| Revenue Estimate | $251.72M | |
| Revenue Est. Change | +21.29% | |
| Current Price | $17.98 | |
| Price Target | - | $28.00 |
| Price Tgt. Change | - | +55.73% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.60 | $0.54 | -9.50% | |
| -$2.59 | -$2.58 | +0.39% | |
| -$2.03 | N/A | +21.36% | |
| -$1.10 | N/A | +57.28% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $221.18M | $216.67M | -2.04% | |
| $202.24M | $207.54M | +2.62% | |
| $251.72M | N/A | +21.29% | |
| $303.17M | N/A | +46.08% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -11.86% | |
| Price, 3Y | -3.80% | |
| Market Cap, 1Y | -10.91% | |
| Market Cap, 3Y | -0.65% | |
| Revenue, 1Y | -4.21% | |
| Revenue, 3Y | +50.47% | |
| EPS, 1Y | -574.22% | |
| EPS, 3Y | -81.07% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $17.98 | |
| SMA 200 | $20.62 | |
| SMA 200 vs Price | +14.69% | |
| SMA 50 | $18.48 | |
| SMA 50 vs Price | +2.79% | |
| Beta | 1.37 | |
| ATR | $0.73 | |
| 14-Day RSI | 49.09 | |
| 10-Day Volatility | 59.04% | |
| 1-Year Volatility | 62.76% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $207.54M | |
| EPS | -$2.58 | |
| Gross Profit | $132.08M | |
| Gross Margin | 63.64% | |
| Operating Profit | -$209.30M | |
| Operating Margin | -100.85% | |
| Net Income | -$187.12M | |
| Net Margin | -90.16% | |
| EBITDA | -$203.14M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| Current Ratio | 3.31 | |
| Quick Ratio | 3.31 | |
| - | ||
| F-Score | 4 | |
| Altman Z-Score | 1.14 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 5.15 | |
| PB Ratio | 4.12 | |
| EV/EBITDA | -6.30 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $421.45M | |
| Cash & Equivalents | $147.33M | |
| Total Assets | $823.23M | |
| Current Assets | $634.99M | |
| Total Liabilities | $401.78M | |
| Current Liabilities | $191.75M | |
| Total Debt | $117.83M | |
| Short Term Debt | $16.76M | |
| Accounts Payable | $10.67M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $416.84M | |
| Operating Expenses | $341.38M | |
| Cost Of Goods Sold | $75.46M | |
| SG&A | $139.59M | |
| D&A | $6.16M | |
| Interest Expense | $0.00 | |
| Income Tax | $1.41M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$157.37M | |
| CFI | $148.84M | |
| CFF | $10.12M | |
| Capex | $7.31M | |
| Free Cash Flow | -$164.68M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B of A Securities | → | |
| Keybanc | → | |
| Goldman Sachs | ||
| Morgan Stanley | → | |
| Citigroup | → | |
| Barclays | ||
| Keybanc | → | |
| Keybanc | → | |
| Piper Sandler | → | |
| Keybanc | → |
Analyst sentiment
Institutional ownership
Screeners with SDGR
Data Sources & References
- SDGR Official Website www.schrodinger.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1490978/000149097825000117/0001490978-25-000117-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1490978/000149097825000014/0001490978-25-000014-index.htm
- SDGR Profile on Yahoo Finance finance.yahoo.com/quote/SDGR
- SDGR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sdgr
FAQ
What is the ticker symbol for Schrödinger, Inc.?
The ticker symbol for Schrödinger, Inc. is NASDAQ:SDGR
Does Schrödinger, Inc. pay dividends?
No, Schrödinger, Inc. does not pay dividends
What sector is Schrödinger, Inc. in?
Schrödinger, Inc. is in the Healthcare sector
What industry is Schrödinger, Inc. in?
Schrödinger, Inc. is in the Health Information Services industry
What country is Schrödinger, Inc. based in?
Schrödinger, Inc. is headquartered in United States
When did Schrödinger, Inc. go public?
Schrödinger, Inc. initial public offering (IPO) was on February 6, 2020
Is Schrödinger, Inc. in the S&P 500?
No, Schrödinger, Inc. is not included in the S&P 500 index
Is Schrödinger, Inc. in the NASDAQ 100?
No, Schrödinger, Inc. is not included in the NASDAQ 100 index
Is Schrödinger, Inc. in the Dow Jones?
No, Schrödinger, Inc. is not included in the Dow Jones index
When was Schrödinger, Inc. last earnings report?
Schrödinger, Inc.'s most recent earnings report was on November 5, 2025
When does Schrödinger, Inc. report earnings?
The next expected earnings date for Schrödinger, Inc. is February 25, 2026
